ScienceTech.euabout 1 hour ago
AquaNab raises funding for alpaca nanoantibody sea lice treatment
2 min read
Hamburg biotech AquaNab secured investment from Finland's Nordic Foodtech VC for its alpaca-derived nanoantibodies, delivered via feed, to treat sea lice in Atlantic salmon. The parasite costs aquaculture about $4 billion annually. The funding is Nordic Foodtech VC's first outside the Nordic region.
Level
Hype check
Tap to vote and see what everyone thinks.
